137 related articles for article (PubMed ID: 24948381)
1. Looking ahead: electroretinographic anomalies, glycogen synthase kinase-3, and biomarkers for neuropsychiatric disorders.
Chen G; Henter ID; Manji HK
Biol Psychiatry; 2014 Jul; 76(2):86-8. PubMed ID: 24948381
[No Abstract] [Full Text] [Related]
2. Glycogen synthase kinase-3 overexpression replicates electroretinogram anomalies of offspring at high genetic risk for schizophrenia and bipolar disorder.
Lavoie J; Hébert M; Beaulieu JM
Biol Psychiatry; 2014 Jul; 76(2):93-100. PubMed ID: 24138923
[TBL] [Abstract][Full Text] [Related]
3. Looking beyond the role of glycogen synthase kinase-3 genetic expression on electroretinogram response: what about lithium?
Lavoie J; Hébert M; Beaulieu JM
Biol Psychiatry; 2015 Feb; 77(3):e15-e17. PubMed ID: 25193244
[No Abstract] [Full Text] [Related]
4. GSK-3β polymorphism discriminates bipolar disorder and schizophrenia: a systematic meta-analysis.
Tang H; Shen N; Jin H; Liu D; Miao X; Zhu LQ
Mol Neurobiol; 2013 Dec; 48(3):404-11. PubMed ID: 23440732
[TBL] [Abstract][Full Text] [Related]
5. Region-specific dysregulation of glycogen synthase kinase-3β and β-catenin in the postmortem brains of subjects with bipolar disorder and schizophrenia.
Pandey GN; Rizavi HS; Tripathi M; Ren X
Bipolar Disord; 2015 Mar; 17(2):160-71. PubMed ID: 25041379
[TBL] [Abstract][Full Text] [Related]
6. No association of two common SNPs at position -1727 A/T, -50 C/T of GSK-3 beta polymorphisms with schizophrenia and bipolar disorder of Korean population.
Lee KY; Ahn YM; Joo EJ; Jeong SH; Chang JS; Kim SC; Kim YS
Neurosci Lett; 2006 Mar; 395(2):175-8. PubMed ID: 16289845
[TBL] [Abstract][Full Text] [Related]
7. Further evidence on the lack of association between glycogen synthase kinase 3beta gene polymorphisms and bipolar disorder.
Scassellati C; Rotondo A; Bonvicini C; Rossi G; Cassano GB; Gennarelli M
Psychiatr Genet; 2007 Aug; 17(4):249-50. PubMed ID: 17621172
[No Abstract] [Full Text] [Related]
8. Association analysis of the GSK-3beta T-50C gene polymorphism with schizophrenia and bipolar disorder.
Szczepankiewicz A; Skibinska M; Hauser J; Slopien A; Leszczynska-Rodziewicz A; Kapelski P; Dmitrzak-Weglarz M; Czerski PM; Rybakowski JK
Neuropsychobiology; 2006; 53(1):51-6. PubMed ID: 16397405
[TBL] [Abstract][Full Text] [Related]
9. Association study of the glycogen synthase kinase-3beta gene polymorphism with prophylactic lithium response in bipolar patients.
Szczepankiewicz A; Rybakowski JK; Suwalska A; Skibinska M; Leszczynska-Rodziewicz A; Dmitrzak-Weglarz M; Czerski PM; Hauser J
World J Biol Psychiatry; 2006; 7(3):158-61. PubMed ID: 16861141
[TBL] [Abstract][Full Text] [Related]
10. What can a clock mutation in mice tell us about bipolar disorder?
Coyle JT
Proc Natl Acad Sci U S A; 2007 Apr; 104(15):6097-8. PubMed ID: 17404212
[No Abstract] [Full Text] [Related]
11. Glycogen synthase kinase 3 beta gene structural variants as possible risk factors of bipolar depression.
Ronai Z; Kovacs-Nagy R; Szantai E; Elek Z; Sasvari-Szekely M; Faludi G; Benkovits J; Rethelyi JM; Szekely A
Am J Med Genet B Neuropsychiatr Genet; 2014 Apr; 165B(3):217-22. PubMed ID: 24677591
[TBL] [Abstract][Full Text] [Related]
12. [Role of glycogen synthase kinase-3β in the pathogenesis of mental disorders].
Ivanova SA; Losenkov IS; Bokhan NA
Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(6):93-100. PubMed ID: 25075421
[TBL] [Abstract][Full Text] [Related]
13. A glycogen synthase kinase 3-beta promoter gene single nucleotide polymorphism is associated with age at onset and response to total sleep deprivation in bipolar depression.
Benedetti F; Serretti A; Colombo C; Lorenzi C; Tubazio V; Smeraldi E
Neurosci Lett; 2004 Sep; 368(2):123-6. PubMed ID: 15351432
[TBL] [Abstract][Full Text] [Related]
14. The impact of glycogen synthase kinase 3β gene on psychotic mania in bipolar disorder patients.
Lee YJ; Kim YK
Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jul; 35(5):1303-8. PubMed ID: 21549170
[TBL] [Abstract][Full Text] [Related]
15. A single nucleotide polymorphism in glycogen synthase kinase 3-beta promoter gene influences onset of illness in patients affected by bipolar disorder.
Benedetti F; Bernasconi A; Lorenzi C; Pontiggia A; Serretti A; Colombo C; Smeraldi E
Neurosci Lett; 2004 Jan; 355(1-2):37-40. PubMed ID: 14729229
[TBL] [Abstract][Full Text] [Related]
16. Long-term response to lithium salts in bipolar illness is influenced by the glycogen synthase kinase 3-beta -50 T/C SNP.
Benedetti F; Serretti A; Pontiggia A; Bernasconi A; Lorenzi C; Colombo C; Smeraldi E
Neurosci Lett; 2005 Mar; 376(1):51-5. PubMed ID: 15694273
[TBL] [Abstract][Full Text] [Related]
17. β-catenin promoter ChIP-chip reveals potential schizophrenia and bipolar disorder gene network.
Pedrosa E; Shah A; Tenore C; Capogna M; Villa C; Guo X; Zheng D; Lachman HM
J Neurogenet; 2010 Dec; 24(4):182-93. PubMed ID: 20615089
[TBL] [Abstract][Full Text] [Related]
18. [Association between lithium sensitivity and GSK3beta gene polymorphisms in bipolar disorder].
Numajiri M; Aoki J; Iwahashi K; Fukamauchi F; Enomoto M; Yoshihara E; Murayama O; Nishizawa D; Ikeda K; Ishigooka J
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Jun; 32(3):161-3. PubMed ID: 22834106
[TBL] [Abstract][Full Text] [Related]
19. Retinal response to light in young nonaffected offspring at high genetic risk of neuropsychiatric brain disorders.
Hébert M; Gagné AM; Paradis ME; Jomphe V; Roy MA; Mérette C; Maziade M
Biol Psychiatry; 2010 Feb; 67(3):270-4. PubMed ID: 19833322
[TBL] [Abstract][Full Text] [Related]
20. Retinal function anomalies in young offspring at genetic risk of schizophrenia and mood disorder: The meaning for the illness pathophysiology.
Gagné AM; Moreau I; St-Amour I; Marquet P; Maziade M
Schizophr Res; 2020 May; 219():19-24. PubMed ID: 31320175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
